← Reviews
Open AccessVollständige AnalyseJun 21, 2026

Clinical trial of the effects of postbiotic supplementation on inflammation, oxidative stress, and clinical outcomes in patients with CVA

The submitted full text contains only the Introduction section repeated three times — no quantitative data, effect direction, or confidence intervals can be extracted.

The question (PICO)
PopulationHospitalized adult patients diagnosed with cerebrovascular accident (stroke/CVA)
InterventionPostbiotic supplementation (non-viable microbial components; strain/dose/formulation not specifiable from provided text)
VergleichControl group (placebo or standard treatment — not specifiable from provided text)
EndpunktInflammatory markers, oxidative stress markers, and clinical outcomes (specific metrics not extractable from provided text)
DEvidenz
Studie
Randomized controlled trial
Effekt
Unzureichend
Zusammenfassung der Ergebnisse nach Endpunkt
EndpunktGradRichtungEffektStudien
Inflammatory markers (e.g., CRP, IL-6)D Unzureichendnot extractable — full text not provided
Oxidative stress markers (e.g., MDA, SOD)D Unzureichendnot extractable — full text not provided
Neurological clinical outcomes (e.g., modified Rankin Scale)D Unzureichendnot extractable — full text not provided
Gastrointestinal complications (diarrhea, constipation, infection)D Unzureichendnot extractable — full text not provided
Inflammatory markers (e.g., CRP, IL-6)D
Richtung Unzureichend
Effektnot extractable — full text not provided
Studien
Oxidative stress markers (e.g., MDA, SOD)D
Richtung Unzureichend
Effektnot extractable — full text not provided
Studien
Neurological clinical outcomes (e.g., modified Rankin Scale)D
Richtung Unzureichend
Effektnot extractable — full text not provided
Studien
Gastrointestinal complications (diarrhea, constipation, infection)D
Richtung Unzureichend
Effektnot extractable — full text not provided
Studien

Kontext

Stroke triggers neuronal damage via oxidative stress and inflammation; post-stroke gut dysbiosis is associated with worse prognosis. Postbiotics (non-viable microbial components) offer immunomodulatory and antioxidant properties with greater stability than probiotics. This is presented as the first RCT evaluating postbiotics in stroke patients.

Was die Studie zeigte

Methods, Results, and Discussion sections were not provided — only the Introduction was submitted, repeated verbatim three times. No quantitative data, p-values, effect sizes, or confidence intervals can be extracted. Full critical appraisal is not feasible.

Wie es durchgeführt wurde

Described as a clinical trial published in Scientific Reports (October 2024). Study design, sample size, duration, inclusion/exclusion criteria, randomization, blinding, and intervention protocol are unavailable from the provided text.

Effektgröße

No effect size extractable. No 95% CI available. Quantitative estimation is impossible with the provided text.

Einschränkungen

RoB 2 assessment (standard tool for RCTs) cannot be applied without complete Methods and Results sections. The submitted text consists solely of the Introduction, replicated across all three requested sections. Selection, performance, detection, and attrition biases cannot be evaluated.

In der klinischen Praxis

No clinical recommendation can be derived from the available text alone. Clinicians should not modify practice based on this incomplete submission. Full data must be reviewed before any interpretation.

Was noch fehlt

Access to the complete manuscript with Methods, Results, and Discussion is essential. Multicenter RCTs with ≥90-day follow-up, validated functional outcomes (e.g., modified Rankin Scale), and longitudinal microbiome profiling are the field's next research priorities.

Microbiota Weekly

Die Mikrobiota-Evidenz der Woche, in Ihrer Sprache. Strukturierte Zusammenfassungen, rückverfolgbar zur Quelle.